{"url":"https://lda.senate.gov/api/v1/filings/d70be4bb-e8ac-4ed2-9ed1-171d5772a6a7/","filing_uuid":"d70be4bb-e8ac-4ed2-9ed1-171d5772a6a7","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2016,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d70be4bb-e8ac-4ed2-9ed1-171d5772a6a7/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Daniel R. Murphy","dt_posted":"2016-04-21T14:25:01.640000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Thirteenth Street, NW","registrant_address_2":"Eleventh Floor South","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":5357,"url":"https://lda.senate.gov/api/v1/registrants/5357/","house_registrant_id":31564,"name":"BGR GOVERNMENT AFFAIRS","description":"Lobbying firm","address_1":"601 13th Street, NW","address_2":"11th Floor South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHELSEA MINCHEFF","contact_telephone":"+1 202-661-6385","dt_updated":"2026-01-30T13:07:06.930629-05:00"},"client":{"id":106679,"url":"https://lda.senate.gov/api/v1/clients/106679/","client_id":1006878,"name":"EGALET CORPORATION","general_description":"Pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-03-07"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal legislation pertaining to prescription drug abuse/utilization of abuse deterrent technology","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":58039,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":54906,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"BOYER","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false},{"lobbyist":{"id":62729,"prefix":null,"prefix_display":null,"first_name":"BRENT","nickname":null,"middle_name":"ALAN","last_name":"DEL MONTE","suffix":null,"suffix_display":null},"covered_position":"See prior filing","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}